Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.
Saved in:
| Title: | Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. |
|---|---|
| Authors: | Wenzl K; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Stokes ME; Informatics and Predictive Sciences, , Bristol Myers Squibb, Summit, NJ, USA., Novak JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Bock AM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Khan S; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hopper MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Krull JE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dropik AR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Walker JS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Sarangi V; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Mwangi R; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Ortiz M; Informatics and Predictive Sciences, Celgene Institute for Translational Research Europe (CITRE), Seville, Spain., Stong N; Informatics and Predictive Sciences, , Bristol Myers Squibb, Summit, NJ, USA., Huang CC; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Maurer MJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Rimsza L; Division of Hematopathology, Mayo Clinic, Scottsdale, AZ, USA., Link BK; Division of Hematology, University of Iowa, Iowa, USA., Slager SL; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Asmann Y; Department of Quantitative Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA., Mondello P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Morin R; Genome Sciences Center, British Columbia Cancer Agency, Vancouver, BC, Canada., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., King RL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Nowakowski G; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Cerhan JR; Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Gandhi AK; Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA., Novak AJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Novak.Anne@mayo.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2024 Jun 20; Vol. 14 (1), pp. 100. Date of Electronic Publication: 2024 Jun 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
